Global Coagulation Factor IX Market Research Report 2023

Publication ID:

PB510233645

Publication Date:

October 9, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1.
The global Coagulation Factor IX market is projected to reach US$ 526 million in 2029, increasing from US$ 362 million in 2022, with the CAGR of 5.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Coagulation Factor IX 91制片厂.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Coagulation Factor IX market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Pfizer
CSL Behring
Grifols
Novo Nordisk
Bioverativ
Sanquin
Takeda
Baxter
Aptevo
Segment by Type
Coagulation Factor IX (Plasma Derived)
Coagulation Factor IX (Recombinant)
Segment by Application
Adult
Kids
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Coagulation Factor IX report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Coagulation Factor IX Market Overview
1.1 Product Overview and Scope of Coagulation Factor IX
1.2 Coagulation Factor IX Segment by Type
1.2.1 Global Coagulation Factor IX Market Value Comparison by Type (2023-2029)
1.2.2 Coagulation Factor IX (Plasma Derived)
1.2.3 Coagulation Factor IX (Recombinant)
1.3 Coagulation Factor IX Segment by Application
1.3.1 Global Coagulation Factor IX Market Value by Application: (2023-2029)
1.3.2 Adult
1.3.3 Kids
1.4 Global Coagulation Factor IX Market Size Estimates and Forecasts
1.4.1 Global Coagulation Factor IX Revenue 2018-2029
1.4.2 Global Coagulation Factor IX Sales 2018-2029
1.4.3 Global Coagulation Factor IX Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Coagulation Factor IX Market Competition by Manufacturers
2.1 Global Coagulation Factor IX Sales Market Share by Manufacturers (2018-2023)
2.2 Global Coagulation Factor IX Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Coagulation Factor IX Average Price by Manufacturers (2018-2023)
2.4 Global Coagulation Factor IX Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Coagulation Factor IX, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Coagulation Factor IX, Product Type & Application
2.7 Coagulation Factor IX Market Competitive Situation and Trends
2.7.1 Coagulation Factor IX Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Coagulation Factor IX Players Market Share by Revenue
2.7.3 Global Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Coagulation Factor IX Retrospective Market Scenario by Region
3.1 Global Coagulation Factor IX Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Coagulation Factor IX Global Coagulation Factor IX Sales by Region: 2018-2029
3.2.1 Global Coagulation Factor IX Sales by Region: 2018-2023
3.2.2 Global Coagulation Factor IX Sales by Region: 2024-2029
3.3 Global Coagulation Factor IX Global Coagulation Factor IX Revenue by Region: 2018-2029
3.3.1 Global Coagulation Factor IX Revenue by Region: 2018-2023
3.3.2 Global Coagulation Factor IX Revenue by Region: 2024-2029
3.4 North America Coagulation Factor IX Market Facts & Figures by Country
3.4.1 North America Coagulation Factor IX Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Coagulation Factor IX Sales by Country (2018-2029)
3.4.3 North America Coagulation Factor IX Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Coagulation Factor IX Market Facts & Figures by Country
3.5.1 Europe Coagulation Factor IX Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Coagulation Factor IX Sales by Country (2018-2029)
3.5.3 Europe Coagulation Factor IX Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Coagulation Factor IX Market Facts & Figures by Country
3.6.1 Asia Pacific Coagulation Factor IX Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Coagulation Factor IX Sales by Country (2018-2029)
3.6.3 Asia Pacific Coagulation Factor IX Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Coagulation Factor IX Market Facts & Figures by Country
3.7.1 Latin America Coagulation Factor IX Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Coagulation Factor IX Sales by Country (2018-2029)
3.7.3 Latin America Coagulation Factor IX Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Coagulation Factor IX Market Facts & Figures by Country
3.8.1 Middle East and Africa Coagulation Factor IX Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Coagulation Factor IX Sales by Country (2018-2029)
3.8.3 Middle East and Africa Coagulation Factor IX Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Coagulation Factor IX Sales by Type (2018-2029)
4.1.1 Global Coagulation Factor IX Sales by Type (2018-2023)
4.1.2 Global Coagulation Factor IX Sales by Type (2024-2029)
4.1.3 Global Coagulation Factor IX Sales Market Share by Type (2018-2029)
4.2 Global Coagulation Factor IX Revenue by Type (2018-2029)
4.2.1 Global Coagulation Factor IX Revenue by Type (2018-2023)
4.2.2 Global Coagulation Factor IX Revenue by Type (2024-2029)
4.2.3 Global Coagulation Factor IX Revenue Market Share by Type (2018-2029)
4.3 Global Coagulation Factor IX Price by Type (2018-2029)
5 Segment by Application
5.1 Global Coagulation Factor IX Sales by Application (2018-2029)
5.1.1 Global Coagulation Factor IX Sales by Application (2018-2023)
5.1.2 Global Coagulation Factor IX Sales by Application (2024-2029)
5.1.3 Global Coagulation Factor IX Sales Market Share by Application (2018-2029)
5.2 Global Coagulation Factor IX Revenue by Application (2018-2029)
5.2.1 Global Coagulation Factor IX Revenue by Application (2018-2023)
5.2.2 Global Coagulation Factor IX Revenue by Application (2024-2029)
5.2.3 Global Coagulation Factor IX Revenue Market Share by Application (2018-2029)
5.3 Global Coagulation Factor IX Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Coagulation Factor IX Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 CSL Behring
6.2.1 CSL Behring Corporation Information
6.2.2 CSL Behring Description and Business Overview
6.2.3 CSL Behring Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CSL Behring Coagulation Factor IX Product Portfolio
6.2.5 CSL Behring Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Corporation Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Grifols Coagulation Factor IX Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Novo Nordisk
6.4.1 Novo Nordisk Corporation Information
6.4.2 Novo Nordisk Description and Business Overview
6.4.3 Novo Nordisk Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novo Nordisk Coagulation Factor IX Product Portfolio
6.4.5 Novo Nordisk Recent Developments/Updates
6.5 Bioverativ
6.5.1 Bioverativ Corporation Information
6.5.2 Bioverativ Description and Business Overview
6.5.3 Bioverativ Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bioverativ Coagulation Factor IX Product Portfolio
6.5.5 Bioverativ Recent Developments/Updates
6.6 Sanquin
6.6.1 Sanquin Corporation Information
6.6.2 Sanquin Description and Business Overview
6.6.3 Sanquin Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sanquin Coagulation Factor IX Product Portfolio
6.6.5 Sanquin Recent Developments/Updates
6.7 Takeda
6.6.1 Takeda Corporation Information
6.6.2 Takeda Description and Business Overview
6.6.3 Takeda Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Takeda Coagulation Factor IX Product Portfolio
6.7.5 Takeda Recent Developments/Updates
6.8 Baxter
6.8.1 Baxter Corporation Information
6.8.2 Baxter Description and Business Overview
6.8.3 Baxter Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Baxter Coagulation Factor IX Product Portfolio
6.8.5 Baxter Recent Developments/Updates
6.9 Aptevo
6.9.1 Aptevo Corporation Information
6.9.2 Aptevo Description and Business Overview
6.9.3 Aptevo Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Aptevo Coagulation Factor IX Product Portfolio
6.9.5 Aptevo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Coagulation Factor IX Industry Chain Analysis
7.2 Coagulation Factor IX Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Coagulation Factor IX Production Mode & Process
7.4 Coagulation Factor IX Sales and Marketing
7.4.1 Coagulation Factor IX Sales Channels
7.4.2 Coagulation Factor IX Distributors
7.5 Coagulation Factor IX Customers
8 Coagulation Factor IX Market Dynamics
8.1 Coagulation Factor IX Industry Trends
8.2 Coagulation Factor IX Market Drivers
8.3 Coagulation Factor IX Market Challenges
8.4 Coagulation Factor IX Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Pfizer
CSL Behring
Grifols
Novo Nordisk
Bioverativ
Sanquin
Takeda
Baxter
Aptevo

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.